Skip to main content
icon for 雑草のスケジュールが変更されたのは... ?

雑草のスケジュールが変更されたのは... ?

icon for 雑草のスケジュールが変更されたのは... ?

雑草のスケジュールが変更されたのは... ?

3月 31

3月 31

$768,988 Vol.

2026/03/31
Polymarket

$768,988 Vol.

Polymarket

6月30日

$341,889 Vol.

1%

12月31日

$162,217 Vol.

26%

This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by March 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.The April 2026 Department of Justice order, issued under President Trump’s December 2025 executive order, immediately moved FDA-approved marijuana products and state-licensed medical marijuana into Schedule III while launching an expedited DEA administrative hearing on broader rescheduling from Schedule I. That hearing, set to begin June 29, 2026 and conclude by mid-July, will examine full reclassification and could produce a final rule in the Federal Register shortly afterward. These steps follow the 2024 proposed rulemaking and represent the most recent concrete acceleration of the Controlled Substances Act process. Traders are therefore focused on whether the compressed hearing timeline and any subsequent rulemaking will resolve the broader question before key year-end or quarterly deadlines, with procedural outcomes and potential litigation remaining the primary variables.

This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
音量
$768,988
終了日
2026/03/31
マーケット開始日
Feb 7, 2026, 5:04 PM ET
This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by March 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.The April 2026 Department of Justice order, issued under President Trump’s December 2025 executive order, immediately moved FDA-approved marijuana products and state-licensed medical marijuana into Schedule III while launching an expedited DEA administrative hearing on broader rescheduling from Schedule I. That hearing, set to begin June 29, 2026 and conclude by mid-July, will examine full reclassification and could produce a final rule in the Federal Register shortly afterward. These steps follow the 2024 proposed rulemaking and represent the most recent concrete acceleration of the Controlled Substances Act process. Traders are therefore focused on whether the compressed hearing timeline and any subsequent rulemaking will resolve the broader question before key year-end or quarterly deadlines, with procedural outcomes and potential litigation remaining the primary variables.

This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
音量
$768,988
終了日
2026/03/31
マーケット開始日
Feb 7, 2026, 5:04 PM ET
This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.

外部リンクに注意してください。

よくある質問

「雑草のスケジュールが変更されたのは... ?」はPolymarket上の3個の結果が可能な予測市場で、トレーダーが何が起こるかに基づいてシェアを売買します。現在のリード結果は「12月31日」で26%、次いで「6月30日」が1%です。価格はコミュニティのリアルタイム確率を反映しています。例えば、26¢で取引されているシェアは、市場がその結果に26%の確率を集合的に割り当てていることを意味します。これらのオッズは継続的に変化します。正しい結果のシェアは市場決済時に各$1で引き換え可能です。

本日現在、「雑草のスケジュールが変更されたのは... ?」は$769Kの総取引量を生み出しています(Nov 5, 2025のマーケット開始以来)。この取引活動レベルはPolymarketコミュニティの強い関与を反映し、現在のオッズが幅広い市場参加者によって形成されていることを保証します。このページで直接、ライブの価格変動を追跡し、任意の結果で取引できます。

「雑草のスケジュールが変更されたのは... ?」で取引するには、このページに記載されている3個の利用可能な結果を閲覧します。各結果には市場の暗示確率を表す現在の価格が表示されています。ポジションを取るには、最も可能性が高いと思う結果を選び、「はい」で支持するか「いいえ」で反対するかを選択し、金額を入力して「取引」をクリックします。選んだ結果が市場決済時に正しければ、「はい」のシェアは各$1を支払います。正しくなければ$0です。決済前にいつでもシェアを売却できます。

「雑草のスケジュールが変更されたのは... ?」の現在のフロントランナーは「12月31日」で26%であり、市場がこの結果に26%の確率を割り当てていることを意味します。次に近い結果は「6月30日」で1%です。これらのオッズはトレーダーがシェアを売買するにつれてリアルタイムで更新されます。頻繁に確認するか、このページをブックマークしてください。

「雑草のスケジュールが変更されたのは... ?」の決済ルールは、各結果が勝者と宣言されるために何が起こる必要があるかを正確に定義しています。これには結果を決定するために使用される公式データソースも含まれます。このページのコメント上にある「ルール」セクションで完全な決済基準を確認できます。取引前にルールを注意深く読むことをお勧めします。